ARCHIVES

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Center Program Move Definite; DCBD to Be Renamed

September 22, 1989

NCI Plans Contract To Study Cancer Research Manpower Needs; Epidemiologist State Their Case

October 7, 1977

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

NCI T BE More Flexible In Funding RFAs Above Paylines

June 23, 1989

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

February 3, 2006